- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 17-12-2025: Press Release
17-12-2025 | 11:48 am
17-12-2025 | 11:48 am
Lupin's biosimilar Ranluspec™ received positive EU regulatory opinion, nearing market entry. Sandoz will commercialize it across most of the EU, boosting potential future revenue for the company through this key business development.
No comments yet. Be the first to comment!